Surrozen: three partnerships exercise $11.60 units
The Series E Common Warrants are exercisable immediately and will not expire until exercised in full, subject to certain beneficial ownership limitations.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
On October 20, 2026, three investment partnerships exercised Surrozen, Inc. (SRZN) Second Tranche Units purchased in a private placement and acquired, respectively, 485,830, 548,653, and 517,241 common shares: The Column Group III, LP; The Column Group III-A, LP; and The Column Group Opportunity III, LP. Each unit included one common share and one-half of a Series E Common Warrant. The unit price was $11.60, comprising $11.5375 per share and $0.0625 attributable to accompanying warrants; the warrants have an $11.54 exercise price. No Rule 10b5-1 plan is reported.
The securities are held by the partnerships. Managing partners Peter Svennilson, identified as a ten percent owner, and Tim Kutzkey, a member of Surrozen's board, may be deemed to share voting and investment power; they disclaim beneficial ownership except to the extent of their respective pecuniary interests.
Insider Trade Summary
3,103,448 shares exercised/converted
Exercise
9 txns
Insider
COLUMN GROUP III GP, LP, COLUMN GROUP III-A, LP, COLUMN GROUP III, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Svennilson Peter
Role
10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| In-the-Money Exercise | Second Tranche Units (Right to Buy) F2, F1, F6, F3 | 728,745 | -- | -- |
| In-the-Money Exercise | Second Tranche Units (Right to Buy) F2, F1, F7, F4 | 822,980 | -- | -- |
| In-the-Money Exercise | Second Tranche Units (Right to Buy) F2, F1, F8, F5 | 775,861 | -- | -- |
| In-the-Money Exercise | Series E Common Warrants F1, F9, F3 | 242,915 | -- | -- |
| In-the-Money Exercise | Series E Common Warrants F1, F9, F4 | 274,327 | -- | -- |
| In-the-Money Exercise | Series E Common Warrants F1, F9, F5 | 258,620 | -- | -- |
| In-the-Money Exercise | Common Stock F1, F2, F3 | 485,830 | $11.60 | $5.64M |
| In-the-Money Exercise | Common Stock F1, F2, F4 | 548,653 | $11.60 | $6.36M |
| In-the-Money Exercise | Common Stock F1, F2, F5 | 517,241 | $11.60 | $6.00M |
Holdings After Transaction:
Second Tranche Units (Right to Buy) — 0 contracts (Indirect, By The Column Group III, LP);
Second Tranche Units (Right to Buy) — 0 contracts (Indirect, By The Column Group III-A, LP);
Second Tranche Units (Right to Buy) — 0 contracts (Indirect, By The Column Group Opportunity III, LP);
Series E Common Warrants — 404,858 contracts (Indirect, By The Column Group III, LP);
Series E Common Warrants — 457,211 contracts (Indirect, By The Column Group III-A, LP);
Series E Common Warrants — 431,034 contracts (Indirect, By The Column Group Opportunity III, LP);
Common Stock — 1,386,122 shares (Indirect, By The Column Group III, LP);
Common Stock — 1,565,311 shares (Indirect, By The Column Group III-A, LP);
Common Stock — 862,068 shares (Indirect, By The Column Group Opportunity III, LP)
Footnotes (9)
- F1. Each Second Tranche Unit consists of (a) one share of the Issuer's Common Stock and (b) one half of a Series E Common Warrant to purchase shares of Common Stock. The Second Tranche Units were purchased in the Issuer's private placement on October 20, 2026 (the "2026 Private Placement").
- F2. Represents a price per unit, consisting of (i) $11.5375 per share of the Issuer's Common Stock and (ii) $0.0625 attributable to accompanying warrants to purchase shares of the Issuer's Common Stock, which The Column Group III, LP ("TCG III LP"), The Column Group III-A, LP ("TCG III-A LP") and The Column Group Opportunity III, LP ("TCG Opportunity III LP") purchased in the Issuer's 2026 Private Placement.
- F3. The securities are directly held by The Column Group III, LP ("TCG III LP"). The Column Group III GP, LP ("TCG III GP") is the general partner of TCG III LP and may be deemed to have voting, investment and dispositive power with respect to these securities. The managing partners of TCG III GP are Peter Svennilson and Tim Kutzkey, a member of the Issuer's board of directors (collectively, the "Managing Partners"). The Managing Partners may be deemed to share voting and investment power with respect to such securities. TCG III GP and each of the Managing Partners disclaim beneficial ownership of these securities, except to the extent of their respective pecuniary interest in such securities.
- F4. The securities are directly held by The Column Group III-A, LP ("TCG III-A LP"). TCG III GP is the general partner of TCG III-A LP and may be deemed to have voting, investment and dispositive power with respect to these securities. The managing partners of TCG III GP are the Managing Partners. The Managing Partners may be deemed to share voting and investment power with respect to such securities. TCG III GP and each of the Managing Partners disclaim beneficial ownership of these securities, except to the extent of their respective pecuniary interest in such securities.
- F5. The securities are directly held by The Column Group Opportunity III, LP ("TCG Opportunity III LP"). The Column Group Opportunity III GP, LP ("TCG Opportunity III GP LP") is the general partner of TCG Opportunity III LP and may be deemed to have voting, investment and dispositive power with respect to these securities. TCG Opportunity III GP, LLC ("TCG Opportunity III GP LLC") is the general partner of TCG Opportunity III GP LP and the ultimate general partner of TCG Opportunity III LP and may be deemed to have voting, investment and dispositive power with respect to these securities. The managing members of TCG Opportunity III GP LLC are the Managing Partners. TCG Opportunity III GP LP, TCG Opportunity III GP LLC and each of the Managing Partners disclaim beneficial ownership of these securities, except to the extent of their respective pecuniary interest in such securities.
- F6. Consists of (a) 485,830 shares of the Issuer's Common Stock and (b) 242,915 Series E Common Warrants to purchase shares of the Issuer's Common Stock.
- F7. Consists of (a) 548,653 shares of the Issuer's Common Stock and (b) 274,327 Series E Common Warrants to purchase shares of the Issuer's Common Stock.
- F8. Consists of (a) 517,241 shares of the Issuer's Common Stock and (b) 258,620 Series E Common Warrants to purchase shares of the Issuer's Common Stock.
- F9. These Series E Common Warrants are exercisable immediately and will not expire until exercised in full (subject to certain beneficial ownership limitations).
Key Figures
Common shares acquired by The Column Group III, LP: 485,830 shares
Common shares acquired by The Column Group III-A, LP: 548,653 shares
Common shares acquired by The Column Group Opportunity III, LP: 517,241 shares
+5 more
8 metrics
Common shares acquired by The Column Group III, LP
485,830 shares
October 20, 2026 transaction
Common shares acquired by The Column Group III-A, LP
548,653 shares
October 20, 2026 transaction
Common shares acquired by The Column Group Opportunity III, LP
517,241 shares
October 20, 2026 transaction
Series E Common Warrants held after transaction by The Column Group III, LP
404,858 warrants
Reported position after October 20, 2026 transaction
Series E Common Warrants held after transaction by The Column Group III-A, LP
457,211 warrants
Reported position after October 20, 2026 transaction
Series E Common Warrants held after transaction by The Column Group Opportunity III, LP
431,034 warrants
Reported position after October 20, 2026 transaction
Second Tranche Unit price
$11.60 per unit
October 20, 2026 private placement
Series E Common Warrant exercise price
$11.54 per share
Warrants acquired in the October 20, 2026 transaction
Key Terms
Second Tranche Units, Series E Common Warrants, beneficial ownership limitations, pecuniary interest
4 terms
Second Tranche Units financial
"Second Tranche Units (Right to Buy)"
Series E Common Warrants financial
"one half of a Series E Common Warrant"
beneficial ownership limitations regulatory
"subject to certain beneficial ownership limitations"
Beneficial ownership limitations are rules or contractual caps that restrict how much of a company’s stock an individual or entity can be treated as owning or controlling for legal, regulatory or corporate-governance purposes. They matter to investors because such limits affect voting power, reporting obligations, takeover risk and the ability to increase a stake — like an elevator weight limit or a lane divider that prevents any one car from taking over the whole road.
pecuniary interest financial
"except to the extent of their respective pecuniary interest"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What are the SRZN Series E Common Warrant amounts and terms?
On October 20, 2026, The Column Group III, LP acquired 242,915 warrants, The Column Group III-A, LP acquired 274,327, and The Column Group Opportunity III, LP acquired 258,620. The warrants have an $11.54 exercise price, are exercisable immediately, and will not expire until exercised in full, subject to certain beneficial ownership limitations.
AI-generated analysis. How Rhea-AI works. Not financial advice.
